Peptides Explained: What They Are, How They Work, and Which Ones Are FDA-Approved

Peptides are short chains of amino acids that act as signaling molecules in the body. Some are FDA-approved medicines, such as insulin, semaglutide, tirzepatide, and tesamorelin. Others are compounded for individual patients or sold online as gray-market “research peptides.” A licensed clinician can help decide whether any peptide fits your goals and health history.

What are peptides?

Peptides are short chains of amino acids, the same building blocks that make up proteins. Many peptides work like messages: they bind to receptors and help coordinate processes such as blood sugar control, appetite, growth hormone signaling, immune activity, and tissue repair 7.

Your body makes many peptides on its own. These are called endogenous peptides. Peptides that come from outside the body, such as prescription medicines, compounded medications, supplements, or lab-made chemicals, are called exogenous peptides 7.

The word “peptide” describes a structure, not one single treatment. Insulin, semaglutide, tirzepatide, tesamorelin, collagen peptides, BPC-157, GHK-Cu, CJC-1295, and TB-500 are all discussed as peptides, but they have very different evidence, risks, and legal status 1 2 3 4 6 7.

How are peptides different from proteins?

Peptides vs proteins mainly comes down to size and shape. Peptides are usually shorter amino-acid chains, while proteins are larger and often fold into complex structures that let them act as enzymes, antibodies, transporters, or structural tissue 7.

There is no single cutoff that works for every molecule. A useful rule is this: peptide medicines often target signaling pathways, while protein medicines often replace or modify larger body functions. In both groups, the effect depends on the exact molecule, not the label “peptide” or “protein” 7.

What do peptides do in the body?

Peptides can act like body signals, and one peptide can have a very different job from another. Depending on the molecule, peptides may help regulate insulin release, appetite, digestion speed, growth hormone release, inflammation signaling, skin structure, or tissue-repair pathways 1 2 3 4 7.

Insulin is a peptide hormone that helps move glucose from the blood into cells and is FDA-approved for diabetes care in multiple forms 1. Its main safety issue is low blood sugar, which can be serious, so dosing and monitoring require clinician guidance 1.

GLP-1 receptor agonists are peptide-based medicines that affect appetite, insulin, glucagon, and stomach emptying. Semaglutide, sold under brand names including Ozempic and Wegovy, is one example; tirzepatide, sold under brand names including Mounjaro and Zepbound, is a GIP/GLP-1 receptor agonist 2 3. These medicines can also cause nausea, vomiting, diarrhea, constipation, gallbladder problems, pancreatitis warnings, and specific thyroid-tumor contraindications on their labels 2 3.

Growth hormone–axis peptides work differently. Tesamorelin is a growth hormone–releasing factor analog approved for reducing excess abdominal fat in adults with HIV and lipodystrophy, while sermorelin is a growth hormone–releasing hormone analog used in specific clinical contexts and compounded care settings 4 10. These pathways can affect IGF-1, glucose, fluid retention, and injection-site reactions, so screening and follow-up matter 4.

What types of peptides exist?

Peptide products fall into 5 practical groups: peptides your body makes, dietary peptides, FDA-approved peptide medications, compounded peptides, and gray-market research peptides. These groups are not interchangeable 5 7.

Endogenous peptides your body makes

Endogenous peptides are made inside the body. Insulin is one example: beta cells in the pancreas release insulin to help control blood glucose, and insulin deficiency or resistance is central to diabetes care 1.

The mechanism can be powerful, but “natural” does not mean “risk-free.” Insulin therapy can cause hypoglycemia, weight gain, and injection-site reactions, and it can interact with changes in food intake, exercise, kidney function, and other glucose-lowering medicines 1.

Dietary and collagen peptides

Collagen peptides are broken-down collagen proteins, often sold as dietary supplements. They are usually taken by mouth and are digested into smaller peptides and amino acids that may support collagen turnover in skin and connective tissue 11.

Human studies have investigated collagen peptides for skin hydration, elasticity, wrinkles, and joint symptoms. In a systematic review of randomized controlled trials, oral collagen supplements were associated with improved skin measures in some studies, but products, doses, study quality, and outcomes varied 11. Expectations should be modest, and individual results vary.

Risks are usually milder than prescription peptide risks, but quality still matters. Collagen supplements can cause digestive symptoms, may not fit certain allergies or diets, and do not go through the same FDA premarket review as prescription drugs 12.

FDA-approved peptide medications

Some peptide medications are FDA-approved after review for specific uses. Examples include insulin products for diabetes, semaglutide products such as Ozempic and Wegovy, tirzepatide products such as Mounjaro and Zepbound, and tesamorelin sold as Egrifta SV for excess abdominal fat in adults with HIV and lipodystrophy 1 2 3 4.

FDA approval is not a blanket “safe for everyone” signal. Each drug has labeled uses, side effects, contraindications, drug interactions, and monitoring needs. For example, semaglutide and tirzepatide labels include gastrointestinal side effects and a contraindication for people with a personal or family history of medullary thyroid carcinoma or MEN2 2 3.

Compounded peptides from licensed pharmacies

Compounded peptides may be prepared by a licensed 503A compounding pharmacy for an individual patient when a prescriber determines it is clinically appropriate and legal requirements are met. The key safety theme is licensed care: a real clinical evaluation, a patient-specific prescription, a licensed pharmacy, and follow-up 5.

At Chia, our providers evaluate patients online for select options in our catalog, including semaglutide injections, tirzepatide tablets or injections, NAD+ injection or nasal spray, sermorelin injection, nasal spray, or tablets, and glutathione injection or nasal spray, when clinically appropriate. Medications are compounded in the US by state-licensed 503A pharmacies and shipped to the patient’s door.

Research or gray-market peptides

Gray-market research peptides are often sold online with labels such as “not for human use.” These products may have unknown purity, concentration, sterility, storage history, contamination risk, or legal status 5 6.

BPC-157 is a synthetic peptide fragment of a body-protective compound studied mostly in animals for tendon, gut, and wound-healing pathways. Animal studies suggest effects on angiogenesis, nitric oxide signaling, and tissue repair, but human evidence is limited, and it is not FDA-approved for healing, pain, sports recovery, longevity, or weight loss 6 13. Safety concerns include uncertain long-term effects, unknown cancer-pathway implications, injection risks, and major quality concerns when bought outside licensed medical channels 5 6.

GHK-Cu, also called copper peptide, is a naturally occurring copper-binding peptide studied in skin biology, wound models, and cosmetic topical use. It may influence collagen, extracellular matrix signaling, and inflammation pathways, but strong clinical trial evidence for injectable anti-aging or hair-growth use is limited, and it is not FDA-approved for those uses 6 14. Topical products may irritate skin, while injectable or gray-market products add sterility, potency, and contamination risks 5.

CJC-1295 is a growth hormone–releasing hormone analog designed to increase growth hormone and IGF-1 signaling. In an early human study, a long-acting CJC-1295 analog increased growth hormone and IGF-1 levels after single injections, but that does not prove broad longevity, body-composition, or performance benefits 15. Possible risks include fluid retention, tingling, joint pain, glucose changes, headache, and concern in people where growth signaling may be unsafe; it is not FDA-approved for anti-aging or muscle gain 6 15.

TB-500 is commonly used online to refer to thymosin beta-4–related peptides. Thymosin beta-4 has been studied in wound healing, inflammation, and cardiac or corneal injury models, but human data for sports recovery, muscle gain, or longevity remain limited, and TB-500 products sold online are not FDA-approved for those uses 6 16. The main risks are uncertain product identity, sterility, immune effects, and lack of combination-specific human safety data 5 6.

Some peptide bulk drug substances are currently under FDA review, with PCAC scheduled to discuss inclusion on the 503A Bulks List on July 23-24, 2026; review is not approval, and FDA.gov should be checked for the latest status 6.

Are peptides the same as Ozempic?

No. Ozempic is one brand name for semaglutide, a GLP-1 receptor agonist peptide-based medication. It is 1 medicine in the peptide category, not the whole category 2.

Ozempic is FDA-approved for type 2 diabetes and cardiovascular risk reduction in certain adults with type 2 diabetes 2. Wegovy is another semaglutide brand, FDA-approved for chronic weight management in certain adults and adolescents and for reducing major adverse cardiovascular events in certain adults with cardiovascular disease and obesity or overweight 17.

Tirzepatide, sold as Mounjaro for type 2 diabetes and Zepbound for chronic weight management and obstructive sleep apnea in certain adults, is a GIP/GLP-1 receptor agonist 3. Compounded semaglutide and compounded tirzepatide may be prepared by licensed 503A pharmacies when legally appropriate, but they should not be described as the same as, generic to, or equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound 5.

In STEP 1, adults with obesity or overweight without diabetes received semaglutide 2.4 mg once weekly plus lifestyle intervention and had greater average weight loss than placebo; individual results vary, and the studied product was not a compounded formulation 8. In SURMOUNT-1, tirzepatide once weekly led to greater average weight reduction than placebo; gastrointestinal side effects were common, individual results vary, and the studied product was not a compounded formulation 9.

Which peptides are FDA-approved?

FDA-approved peptides include many prescription medicines, but there is no simple consumer list that covers every peptide drug. The practical question is the exact active ingredient, brand, labeled use, and prescribing information 1 2 3 4.

What are the potential benefits of peptides?

Peptide benefits depend on the exact molecule, the studied population, and the route. A peptide with strong evidence for one use may have weak evidence for another, and any potential benefit must be weighed with side effects and contraindications 1 2 3 4.

Weight loss and blood sugar with GLP-1s

Semaglutide and tirzepatide are the best-known peptide-related medicines for weight and metabolic care. Semaglutide is a GLP-1 receptor agonist; tirzepatide is a GIP/GLP-1 receptor agonist 2 3.

In STEP 1, participants assigned to semaglutide 2.4 mg once weekly plus lifestyle intervention lost more weight on average than placebo over 68 weeks; individual results vary, and outcomes are not established for compounded formulations 8. In SURMOUNT-1, tirzepatide once weekly produced greater average weight reduction than placebo over 72 weeks; individual results vary, and gastrointestinal side effects were common 9.

The main trade-off is tolerability and screening. GLP-1 and GIP/GLP-1 medicines can cause nausea, vomiting, diarrhea, constipation, dehydration-related kidney issues, gallbladder problems, and pancreatitis warnings; semaglutide and tirzepatide products also have thyroid C-cell tumor contraindications for people with a personal or family history of medullary thyroid carcinoma or MEN2 2 3 17.

Longevity and metabolic health

Longevity peptide claims need careful language. NAD+ is central to cellular redox reactions and energy metabolism, and NAD+ biology has been studied in aging pathways, but human outcomes vary by compound, route, and study design 18.

NAD+ precursors have human trial data showing changes in NAD+ metabolites, but that does not prove broad anti-aging outcomes. Side effects can include nausea, flushing, headache, and route-specific issues such as injection discomfort, so medical history and medication review matter 18.

Sermorelin works on the growth hormone axis by stimulating growth hormone release, which can raise IGF-1. The realistic expectation is not “anti-aging reversal”; it is a clinician-guided discussion about whether GH-axis signaling fits a specific goal and risk profile 10. Risks can include swelling, joint symptoms, headache, flushing, glucose changes, and concern in people where growth signaling may be unsafe 10.

Glutathione is a major intracellular antioxidant and redox molecule. Human studies have examined oral, topical, inhaled, and injectable glutathione in different contexts, but broad longevity benefits are not established 19. Possible risks include digestive symptoms, headache, allergy, injection-site reactions, and bronchospasm concerns with inhaled use in susceptible people 19.

Skin, hair, and collagen

Collagen peptides may support skin hydration and elasticity in some people, based on randomized trials and reviews, but the effect size, timing, and product quality vary 11. They are supplements, not prescription drugs, and they are not a substitute for care of skin disease 12.

GHK-Cu is a copper-binding peptide studied for skin repair biology and extracellular matrix signaling. The evidence is more mature for topical cosmetic use and lab models than for injectable anti-aging use 14. Risks include irritation from topical products and larger uncertainty with injectable products, especially if obtained outside licensed care 5 14.

Muscle recovery and healing

BPC-157 and TB-500/thymosin beta-4 are often discussed online for tendon, muscle, gut, and wound recovery. The honest answer is that much of the evidence is animal, cell, or early-stage research, not large controlled human trials for sports injuries or recovery 13 16.

For BPC-157, animal studies suggest possible effects on angiogenesis, nitric oxide signaling, and soft-tissue repair, but human safety and effectiveness are not established for common wellness uses 13. For thymosin beta-4–related peptides, studies have explored wound and tissue-repair biology, but online TB-500 products may not match studied materials and may carry purity and sterility risks 5 16.

What are the risks and side effects of peptides?

Peptide side effects depend on the exact compound, route, health history, dose studied, product quality, and follow-up plan. A prescription peptide with FDA labeling has known warnings; a gray-market research peptide may have risks that are unknown or poorly measured 1 2 3 5 6.

• Injection-site reactions: redness, pain, itching, swelling, bruising, or infection risk can occur with injected peptide products 1 2 3 4.
• Digestive effects: GLP-1 and GIP/GLP-1 medicines can cause nausea, vomiting, diarrhea, constipation, and abdominal pain 2 3 17.
• Blood sugar changes: insulin can cause hypoglycemia; tesamorelin and GH-axis peptides may affect glucose; GLP-1 medicines can change glucose and insulin signaling 1 2 3 4.
• Gallbladder and pancreas warnings: semaglutide and tirzepatide labels include warnings for gallbladder disease and pancreatitis 2 3 17.
• Hormone-pathway effects: tesamorelin and GH-axis peptides can raise IGF-1, which may require monitoring and may not fit some medical histories 4 10.
• Allergy or immune reactions: any peptide product can cause allergic symptoms, and risk may be higher when product identity or purity is unclear 5.
• Quality risks: gray-market research peptides may have inaccurate concentration, contamination, sterility problems, or misleading labels 5 6.

Seek urgent medical care for severe allergic reaction symptoms, severe belly pain, signs of dehydration, fainting, confusion from possible low blood sugar, or signs of infection after an injection. This is general education, not a diagnosis 1 2 3.

How do you get peptides safely and legally?

The safer path for prescription peptides is licensed clinician evaluation plus a licensed pharmacy. This matters because peptide choice, contraindications, lab monitoring, sterile handling, storage, and follow-up can change the risk-benefit balance 1 2 3 4 5.

1. 1Start with a medical evaluation. Review your health history, medications, allergies, pregnancy status, family history, and goals.
2. 2Define the treatment goal. “Peptides” is too broad; the question is which peptide, for which goal, with what evidence and risk.
3. 3Use a licensed pharmacy. For compounded products, a 503A pharmacy compounds for an individual patient prescription under state and federal rules 5.
4. 4Avoid gray-market research peptides. Online “not for human use” products may not meet medical-grade standards for identity, strength, sterility, or storage 5 6.
5. 5Plan follow-up. Some peptide medicines require side-effect checks, lab monitoring, dose changes, or stopping rules decided by a clinician.

This licensed-care path is the line we emphasize at Chia: clinician review, patient-specific prescribing when appropriate, 503A pharmacy fulfillment, and a care team you can message. That is very different from buying a vial online with no medical review and no reliable way to confirm what is in it 5.

How much do prescription peptides cost, and how can you access them through Chia?

Peptide cost can range from insurance copays to several hundred dollars per month without coverage. The price depends on the medication, form, pharmacy, insurance plan, and care model; FDA labels do not set cash prices.

At Chia, care starts online with a short health questionnaire. A licensed US provider reviews your history and prescribes only when clinically appropriate; a prescription is never guaranteed. Medications in our catalog are compounded in the US by state-licensed 503A compounding pharmacies and shipped to the patient’s door.

For GLP-1 care, Chia offers semaglutide injections, with microdosing plans available, and tirzepatide tablets or injections, also with microdosing plans available. For longevity-focused care, Chia offers NAD+ injection or nasal spray, sermorelin injection, nasal spray, or tablets, and glutathione injection or nasal spray, when clinically appropriate.

When a treatment has more than one form, the choice is practical and clinical. Tablets may be easier for people who want to avoid needles, injections may fit people who prefer less frequent administration or a specific provider-guided plan, and nasal sprays may be considered for certain longevity-focused options in Chia’s catalog. Your provider decides what is appropriate after reviewing your history.

What is the difference between compounded peptides and research peptides?

Compounded peptides are prepared by a licensed pharmacy for a specific patient prescription when legal requirements are met. Research peptides sold online are often not intended for human use and should not be used as a substitute for medical care 5 6.

Frequently asked questions about peptides

Keep reading

Peptides

Peptide Cheat Sheet: Patient Reference to Common Peptides, Uses, and Dosing

Peptides

Peptide Shots: What They Are, How They Work, and Who Should Consider Them

Peptides

Peptides Online: What’s Legal, What’s Safe, and What Actually Works